Christos Faloutsos is the Fredkin Professor of Computer Science at Carnegie Mellon University, with a courtesy appointment in Electrical and Computer Engineering. He holds a B.Sc. from the National Technical University of Athens and M.Sc./Ph.D. from the University of Toronto. His research focuses on data mining, graph analysis, fractals, and database systems. Notable contributions include foundational work on R-trees, graph mining laws (e.g., Kronecker graphs), and applications in medical imaging, network security, and fraud detection. Key projects include PEGASUS (petascale graph mining), fraud detection in online auctions (NetProbe), and tools for human trafficking analysis (TrafficVis). He has led NSF-funded projects on tensor mining, network anomaly detection, and bioinformatics. Over 300 refereed publications highlight his contributions across databases, data mining, and networks. Awards include the KDD Best Paper (2005, 2016), SIGMOD Test-of-Time Award, and recognition as a top nurturer in IT. His lab collaborations span the Parallel Data Lab (PDL), Machine Learning Department, and Computational Biology.
Jonas Fischer is the head of the Explainable Machine Learning group at the Max Planck Institute for Informatics, Department of Computer Vision and Machine Learning. His research focuses on interpreting complex machine learning models, particularly in genomics and healthcare, aiming to enhance robustness and alignment with human decision-making. Prior to his role at MPI, he was a postdoctoral fellow at Harvard University's Department of Biostatistics, where he worked on interpretable models for gene regulatory systems in cancer. Education: PhD in Computer Science from Saarland University (2022), with a thesis titled More than the sum of its parts , exploring the intersection of pattern mining and deep learning. He has contributed to advancing methods in neural network pruning, federated learning, and low-dimensional embeddings (e.g., dtSNE, Mercat). His work bridges computational biology, data mining, and machine learning, with applications in DNA methylation analysis, graph-based differential networks, and biomedical informatics. Key research areas include: (1) Explainable AI and neural network interpretability, (2) Biomedical applications of machine learning (e.g., gene regulatory networks, cancer genomics), (3) Low-dimensional embeddings and visualization techniques, (4) Federated learning for privacy-preserving collaborative models, and (5) Pattern mining for error analysis in NLP and classification tasks. Publications span top venues like NeurIPS, ICLR, Bioinformatics, and Genome Biology. His group develops tools such as BONOBO for omics data integration and node2vec2rank for scalable graph analysis. He actively collaborates with biomedical researchers to address challenges in data-driven healthcare and precision medicine.
Dr. Jimeng Sun is a Health Innovation Professor at the Siebel School of Computing and Data Science and Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign. Co-founder of Keiji AI , he leads groundbreaking research at the intersection of artificial intelligence and healthcare, actively deploying clinical AI systems and developing frameworks like PyHealth and Therapeutics Data Commons . His research spans four major areas: Clinical AI Systems : Developing interpretable models (e.g., RETAIN) for patient similarity, temporal event prediction, medication recommendation, and clinical outcome forecasting Drug Discovery : Creating molecular optimization frameworks, drug-target interaction models, and AI-driven platforms Clinical Trials : Pioneering patient-trial matching, outcome prediction, and optimization frameworks using deep learning and graph neural networks Biosignal Analysis : Advancing sleep staging, seizure classification, and automated EEG/Cardiac monitoring systems With over 500 top-tier publications (including in Nature , NEJM AI , and leading AI conferences) and an h-index of 99, his work has been recognized with the Top 100 AI Leaders in Drug Discovery and Advanced Healthcare award. He maintains active collaborations with institutions like Massachusetts General Hospital , Medidata Solutions , and OSF Healthcare . His recent publications reveal a strong focus on: Reinforcement learning applications in medical data analysis Large language model adaptation for clinical tasks Knowledge graph integration with AI systems Synthetic data generation for healthcare Multi-modal learning in clinical contexts Explainable AI for medical applications Dr. Sun's lab ( Sunlab ) emphasizes practical impact over theoretical work, actively collaborating with hospitals and healthtech companies. He welcomes contributions from clinicians, researchers, and industry partners through initiatives like his AI for Health webinar series .
Philip S. Yu is a Distinguished Professor in the Department of Computer Science at the University of Illinois at Chicago and holds the Wexler Chair in Information Technology. Previously, he led the Software Tools and Techniques department at IBM Thomas J. Watson Research Center. Education: B.S. in Electrical Engineering, National Taiwan University M.S. and Ph.D. in Electrical Engineering, Stanford University M.B.A., New York University His research spans data mining , big data , social networks , privacy-preserving data publishing , graph/network mining , recommender systems , and deep learning . He has authored over 970 papers with 74,500+ citations and an H-index of 127. Recent work focuses on heterogeneous graph representation, quantum walks in network analysis, and federated unlearning. Scientific Honors: ACM SIGKDD 2016 Innovation Award IEEE Computer Society 2013 Technical Achievement Award IEEE ICDM 2003 Research Contributions Award IEEE Region 1 Award (1999) UIC Research of the Year (2013) IBM Master Inventor with 300+ patents AI 2000 Most Influential Scholar Honorable Mentions (2024-2025) He served as Editor-in-Chief for ACM Transactions on Knowledge Discovery from Data and IEEE Transactions on Knowledge and Data Engineering , and on steering committees for ACM KDD and IEEE Data Mining. His work bridges theoretical advances in graph neural networks , deep learning , and privacy-preserving systems with applications in healthcare, social media, and enterprise analytics.
Hadi Meidani is a Clinical Associate Professor at the Carle Illinois College of Medicine , specifically within the Department of Biomedical and Translational Sciences at the University of Illinois at Urbana-Champaign . He teaches courses in Civil and Environmental Engineering, including topics like Systems Engineering & Economics , Machine Learning in CEE , and Uncertainty Quantification . Ph.D., Civil Engineering, University of Southern California (2012) M.S., Electrical Engineering, University of Southern California (2012) M.S., Structural Engineering, Sharif University of Technology (2005) B.S., Civil Engineering, K.N. Toosi University of Technology (2002) Dr. Meidani's research focuses on uncertainty quantification , scientific machine learning , and optimization under uncertainty for engineering systems. His work spans stochastic multiscale analysis , physics-informed machine learning , and model reduction techniques. His recent publications emphasize machine learning for infrastructure systems , graph neural networks , physics-informed models , and traffic assignment . Key trends include deep learning , multi-fidelity modeling , and neural operator transformers applied to metamaterial design , seismic reliability , and autonomous freight delivery .
Professor Chris Holmes is a Professor of Biostatistics at the University of Oxford, where he moved from Imperial College London in February 2004. He is a Fellow at St Anne's College and works in the Department of Statistics. His research focuses on applications and statistical methods development in genomic sciences and genetic epidemiology, holding a prestigious Programme Leaders Grant in Statistical Genomics from the Medical Research Council. Prior to his position at Oxford, Professor Holmes completed his doctorate in Bayesian statistics at Imperial College London, investigating novel nonlinear pattern recognition methods. This was followed by a post-doctoral position and then a lectureship at Imperial. Before his academic career, he worked in industry for several years in scientific computing, developing techniques for real-time pattern recognition models in defense and SCADA systems. Professor Holmes has a broad interest in the theory, methods and applications of statistics and statistical modeling, with a particular foundation in Bayesian statistics which he views as providing a unified framework for stochastic modeling and information processing. His specific research interests include: Bayesian statistics and stochastic simulation Markov chain Monte Carlo methods Pattern recognition and nonlinear, nonparametric methods Spatial statistics Statistical genetics and genomics Genetic epidemiology His recent publications (2023-2025) demonstrate a strong focus on the intersection of biostatistics, artificial intelligence, and healthcare applications. His work spans multiple domains including AI-driven disease classification in neurology, genomic data analysis for health equity, machine learning tools for healthcare prediction, and addressing bias in medical AI systems. A notable trend across his research is the application of advanced statistical methods to solve pressing problems in genomics, epidemiology, and medical diagnostics, with an increasing emphasis on health equity and the ethical implications of AI in healthcare. Professor Holmes currently supervises PhD students Oscar Clivio, Sahra Ghalebikesabi, and Natalia Garcia Martin. His research is supported by multiple grants, including the MRC Programme Leaders Grant in Statistical Genomics which funds his work in statistical genomics. He is actively involved in three research groups at Oxford that reflect the breadth of his scholarly interests: Computational Statistics and Machine Learning Statistical Genetics and Epidemiology Statistical Theory and Methodology
Martin T. Wells is the Charles A. Alexander Professor of Statistical Sciences at Cornell University, with joint appointments in the Department of Statistical Science, Department of Biological Statistics and Computational Biology, Department of Social Statistics, and as Professor of Clinical Epidemiology and Health Services Research at Weill Medical School. He serves as Editor-in-Chief of the ASA-SIAM Book Series and Co-Editor of the Journal of Empirical Legal Studies. Cornell University, Ithaca, NY Weill Cornell Medical College Research Interests span applied and theoretical statistics, Bayesian methods, biostatistics, clinical epidemiology, and computational biology. His work bridges disciplines like finance, legal studies, and health services research. Article Trends highlight advancements in Bayesian modeling, quantum cognition machine learning, tensor analysis, and misclassification correction, with applications in genomics, finance, and public health. Fellow of the American Statistical Association Fellow of the Royal Statistical Society Contributions include developing statistical software (e.g., rTensor), methodological innovations in clinical trials, and empirical legal studies on civil rights and the death penalty.
Aleksandar Jeremic is an Associate Professor in both the Electrical & Computer Engineering department and the McMaster School of Biomedical Engineering at McMaster University. His research focuses on biomedical signal processing, statistical signal processing, and biometrics, with applications in healthcare and biomedical systems. He holds a Dipl. Ing. from the University of Belgrade, and an M.S. and Ph.D. from the University of Illinois at Chicago. His expertise spans physiological signal analysis (e.g., ECG/EEG), medical imaging, and machine learning for biomedical applications. He has authored over 50 technical articles and two book chapters, and has been recognized with a teaching award from the McMaster Electrical and Computer Engineering Society (2018). He supervises graduate students in both theoretical and applied research areas. Dr. Jeremic teaches advanced courses such as Biomedical Signal Modeling and Processing and Advanced Probability and Random Processes , emphasizing practical applications of signal processing in healthcare. His work includes clinical implementations like neonatal seizure monitoring software and microwave imaging for breast cancer detection.
Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.
Mark R. Pittelkow is a Professor of Dermatology at the Mayo Clinic, holding a primary appointment as a Consultant in the Department of Dermatology. He completed his MD at Mayo Medical School and advanced training through Mayo Graduate School of Medicine and Northwestern University. His research focuses on cutaneous lymphomas, photoprotection, and skin cancer, with leadership roles in international guidelines (ISCL/EORTC). He contributes to clinical trials, medical education, and interdisciplinary research through affiliations like the Mayo Clinic Comprehensive Cancer Center and Regenerative Biotherapeutics. Education: MD (Mayo Medical School), MS (Biological Sciences, Northwestern), BA (Northwestern University). Research spans cutaneous lymphoma classification, immunology, and translational dermatology. Notable publications address staging systems for mycosis fungoides/Sezary syndrome and photoprotection strategies. His work integrates clinical practice with molecular mechanisms, such as JAK inhibitor responses in lichen planus. Labs/Teams: Collaborates with Mayo Clinic Cancer Center and interdisciplinary groups in immunotherapy and regenerative medicine. Supervises clinical trials and postdoctoral training programs.
Prof. Dr. Dennis Säring is a faculty member at the University of Applied Sciences Wedel , specifically affiliated with the School of Engineering. His academic and research activities focus on Deep Learning , Medical Image Analysis , and applications of Artificial Intelligence in healthcare and biomedical imaging. He has led seminars on Deep Learning topics and supervised student projects in Autonomous Driving at Audi's AADC 2018 competition. Research Highlights : Cardiovascular imaging, forensic age estimation via MRI, neural network-based bone segmentation, and cerebrovascular aneurysm analysis. Technical Expertise : Cardiac MRI, 3D/4D image processing, parametric mapping, and spatiotemporal data fusion. His recent publications (2018-2023) emphasize 3D MR segmentation for age assessment, CMR strain analysis in athletes, and T1/T2 mapping for myocarditis. Key collaborations include institutions like the University Medical Center Hamburg-Eppendorf and Wedler Hochschulbund, with funding for autonomous vehicle research. While no explicit scientific awards are listed, his work spans clinical cardiology, forensic radiology, and AI-driven medical diagnostics.
Christopher Kanan is a tenured Associate Professor of Computer Science at the University of Rochester, leading the AI Initiative within the Hajim School of Engineering & Applied Sciences. He holds secondary appointments in Brain and Cognitive Sciences, the Goergen Institute for Data Science and AI (GIDS-AI), and the Center for Visual Science. His research focuses on deep learning systems for artificial general intelligence (AGI), including continual learning, medical computer vision, and visual question answering. Previously, he was an Associate Professor at RIT’s Carlson Center for Imaging Science and a leader at Paige.AI, contributing to the FDA-cleared Paige Prostate system. Kanan earned his PhD from UC San Diego, completed postdoctoral work at Caltech, and worked at NASA JPL. Education: PhD in Computer Science, UC San Diego MS in Computer Science, University of Southern California Bachelor’s in Philosophy and Computer Science, Oklahoma State University Research Interests: Kanan’s work spans foundational AI capabilities like continual learning, medical imaging (pathology and radiology), multi-modal reasoning, and cognitive science-inspired models. His lab develops bias-robust AI systems and applies deep learning to healthcare and fusion research. Articles Trends: His recent work emphasizes out-of-distribution generalization, foundation models in pathology, and stability in continual learning. Key themes include AI applications in healthcare, model robustness, and neuroscience-inspired algorithms. Awards: NSF CAREER Award Senior Member, AAAI and IEEE DoE and NSF grants totaling $5M+ DARPA/ARL awards Advising & Grants: Mentored over 10 PhD students, including Robik Shrestha and Usman Mahmood. Secured grants for AI in nuclear fusion and medical imaging. Led RIT’s Center for Human-aware AI (CHAI) as Associate Director. Labs & Teams: Heads the University of Rochester AI Initiative, collaborates with Paige.AI, and leads teams advancing AI in pathology and robotics. His lab’s KLab (klab.cis.rit.edu) focuses on vision and learning systems.
Wing Lam is an Associate Research Scientist in the Department of Pharmacology at the Yale School of Medicine. He holds a BSc in Molecular Biology and a PhD in Biochemical Pharmacology from City University of Hong Kong, followed by postdoctoral training at Yale. His research focuses on developing traditional Chinese medicine (TCM) formulations as adjuvants for cancer therapy, notably YIV-906, which enhances chemotherapy efficacy and mitigates intestinal toxicity. Lam also pioneered the STAR database for herbal drug discovery and the Mechanism-Based Quality Control (MBQC) platform for botanical drug standardization. Education: BSc (Hons) Molecular Biology, City University of Hong Kong, 1995 PhD Biochemical Pharmacology, City University of Hong Kong, 1999 Postdoc, Pharmacology, Yale University, 1999-2002 His research interests span cancer pharmacology, TCM modernization, and mitochondrial toxicity mechanisms. Key projects include YIV-906’s role in enhancing anti-PD1 and CAR T-cell therapies, developing L-nucleoside analogs like troxacitabine, and investigating tylophorine analogs’ antitumor effects. Lam has co-chaired sessions at multiple Consortium for Globalization of Chinese Medicine (CGCM) meetings and contributed to patents on herbal drug formulations and quality control methods. Recent work explores YIV-906’s potential for inflammatory bowel disease (IBD) and phase II clinical trials for colon and liver cancers. Lam’s publications highlight synergistic drug interactions, mitochondrial DNA depletion mechanisms, and TCM’s evidence-based application in chronic diseases. His grants include studies on PHY906 as an adjuvant in rectal cancer therapy and collaborations with Yiviva, Inc. He maintains active roles in editorial boards, including a special issue on herbal drug quality control in Frontiers in Pharmacology . Lam’s lab is embedded within Dr. Yung-Chi Cheng’s group, focusing on translational pharmacology and botanical drug innovation.
Maher Elshakankiri is an Assistant Professor, Teaching Stream at the University of Toronto's Faculty of Information. He holds a Ph.D. in Computer Engineering from Ain Shams University (Egypt), followed by a postdoctoral fellowship at the University of Regina. His research focuses on IoT, Wireless Sensor Networks (WSN), and pedagogical integration of technology and gaming. He has supervised over 100 student projects and authored a book on WSNs. Education: Ph.D. in Computer Engineering, Ain Shams University, Egypt M.Eng., B.Eng. in Engineering, Ain Shams University, Egypt Postdoctoral Fellowship, University of Regina, Canada Research Interests: IoT in healthcare, agriculture, and sports Active learning classrooms and technology in education Wireless communication protocols (V2V, UAV, RFID) Leadership & Grants: Director, Bachelor of Information (BI) Program (2024–present) Coordinator, Information Systems and Design (ISD) Concentration (2023) SSHRC Grant: 'Gaming in teaching towards a more inclusive class' (2022–2023) Professional Activities: Member, SCC IoT & Digital Twins Standards Committee Reviewer for journals including Wireless Networks , Telematics and Informatics , and Computational Intelligence Technical Program Committee member at multiple conferences Teaching: Courses include INF1340 (Programming for Data Science), INF1005/1006 (IoT Workshops), and INF452 (Information Design Coding).
Dr. Jiaqi Gong serves as Associate Professor in Computer Science and Adjunct Associate Professor in Mechanical Engineering at The University of Alabama's College of Engineering, while directing the Alabama Center for the Advancement of Artificial Intelligence. His academic foundation includes: B.S. in Engineering, China University of Geoscience (2004) Ph.D. in Engineering, Huazhong University of Science and Technology (2010) Dr. Gong's research pioneers human-AI convergence through cyber-physical systems and smart health technologies, developing mobile/wearable platforms to enhance human perceptual, cognitive, and physical capabilities. His work spans artificial intelligence, machine learning, computer vision, and IoT with applications in healthcare, environmental monitoring, and education. The Sensor-Accelerated Intelligent Learning (SAIL) laboratory he founded drives innovation in behavior change interventions, human movement modeling, and educational data mining. Recent publications reveal strong interdisciplinary trends: healthcare AI dominates with medication adherence prediction and surgical classification systems, while environmental applications feature flood-risk communication and drought analysis. His work increasingly integrates generative AI and LLMs across domains, demonstrating methodological innovation in federated learning, knowledge graphs, and explainable storytelling frameworks. Notable recognitions include: Best Student Paper Award, IEEE/ACM Connected Health Conference (2022) Best Student Paper Award, Body Sensor Networks Conference (2019) Data Challenge Win, IEEE Biomedical Health Informatics (2018) Best Paper Award, Body Area Networks Conference (2014) Best Demonstration Award, IEEE Wireless Health Conference (2014) Dr. Gong leads significant funded projects including a $2M CDC/NIOSH grant for first responder safety and $3M NSF funding for hydrologic research. As SAIL laboratory director, he mentors students in developing clinically deployed technologies for multiple sclerosis, dementia, and mental health. Future work focuses on scaling AI applications in chronic disease management and climate resilience through the Alabama AI Center. The SAIL laboratory (founded 2017) operates as a multidisciplinary hub developing wearable/mobile systems for health applications, with active collaborations across medical clinics and engineering departments for real-world deployment of behavior change interventions and movement analysis tools.
